Neo Ivy Capital Management’s Immunomedics Inc IMMU Stock Holding History

Neo Ivy Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-430	Closed	-$15K	–	686
2021 Q3	$15K	Buy	+430	New	+$15K	0.02%	406
2020 Q3	–	Sell	-430	Closed	-$15K	–	668
2020 Q2	$15K	Sell	430 -379	-47%	-$11.1K	0.02%	406
2020 Q1	$11K	Sell	809 -29,579	-97%	-$498K	0.02%	417
2019 Q4	$643K	Buy	30,388 +3,939	+15%	+$69.5K	0.74%	62
2019 Q3	$339K	Buy	+26,449	New	+$389K	0.22%	173
2019 Q2	–	Sell	-23,950	Closed	-$460K	–	446
2019 Q1	$460K	Buy	+23,950	New	+$386K	0.26%	157

Neo Ivy Capital Management's IMMU Position: Q4 2021 in Review

Neo Ivy Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2021, closing a stake of 430 shares — an estimated $15K sold.

Neo Ivy Capital Management first reported a position in IMMU in Q1 2019 and held it in 6 quarters. The position peaked at $643K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2021.

Neo Ivy Capital Management reported no remaining Immunomedics Inc position as of Q4 2021 after selling out during the quarter.
Neo Ivy Capital Management sold 430 Immunomedics Inc shares in Q4 2021, an estimated $15K.
Neo Ivy Capital Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 6 quarters.
Neo Ivy Capital Management's Immunomedics Inc position peaked at $643K in Q4 2019.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2021.

Based on Neo Ivy Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.